| Males | Females | ||||||
---|---|---|---|---|---|---|---|---|
Target concentration (mg/m3) | 0 | 0.05 | 0.25 | 5.0 | 0 | 0.05 | 0.25 | 5.0 |
Number examined | 10/10 | 10/0 | 10/10 | 10/10 | 10/10 | 10/0 | 10/10 | 10/10 |
(24Â h/90Â days) | ||||||||
Nasal cavity epithelium, eosinophilic globules | Â | Â | Â | Â | Â | Â | Â | Â |
minimal | 4/2 | - | 2/3 | 2/6 | -/3 | - | 3/2 | 1/4 |
slight | -/1 | - | - | 3/2 | - | - | - | 6/2 |
moderate | - | - | - | 5/2 | - | - | - | 2/3 |
Mean severitya | 0.4/0.4 | - | 0.2/0.3 | 2.3/1.6 | -/0.3 | - | 0.3/0.2 | 1.9/1.7 |
Larynx, squamous metaplasia | Â | Â | Â | Â | Â | Â | Â | Â |
minimal | - | - | 2/- | 4/- | - | - | - | 5/1 |
Mean severitya | - | - | 0.2/- | 0.4/- | - | - | - | 0.5/0.1 |